Variant report
Variant | nsv460966 |
---|---|
Chromosome Location | chr3:163951886-164004812 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163968485..163970197-chr3:163971709..163973734,2 | MCF-7 | breast: | |
2 | chr3:163988892..163990964-chr3:163991912..163993953,2 | K562 | blood: | |
3 | chr3:163968485..163970197-chr3:163971709..163973734,2 | MCF-7 | breast: | |
4 | chr3:163988892..163990964-chr3:163991912..163993953,2 | K562 | blood: | |
5 | chr3:163995585..163997750-chr3:164093655..164096327,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1667783 | chr3:163951886-163951887 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs568665507 | chr3:163951926-163951927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377555007 | chr3:163951929-163951930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138433875 | chr3:163951935-163951936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557599957 | chr3:163951956-163951957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116801932 | chr3:163951978-163951979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545772726 | chr3:163951982-163951983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1796596 | chr3:163951991-163951992 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs573280968 | chr3:163952015-163952016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376034065 | chr3:163952098-163952099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562216745 | chr3:163952114-163952115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531099575 | chr3:163952270-163952271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192360173 | chr3:163952328-163952329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142772670 | chr3:163952375-163952376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13068525 | chr3:163952379-163952380 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs549926102 | chr3:163952399-163952400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546565521 | chr3:163952422-163952423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373927486 | chr3:163952423-163952424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528884209 | chr3:163952428-163952429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548773634 | chr3:163952445-163952446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568624553 | chr3:163952449-163952450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536241871 | chr3:163952459-163952460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537631728 | chr3:163952460-163952461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557563131 | chr3:163952476-163952477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568431869 | chr3:163952478-163952479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73154457 | chr3:163952510-163952511 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs533885096 | chr3:163952544-163952545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367953377 | chr3:163952569-163952570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182102326 | chr3:163952627-163952628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146982435 | chr3:163952661-163952662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138064675 | chr3:163952662-163952663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573668356 | chr3:163952711-163952712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575842400 | chr3:163952725-163952726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374245002 | chr3:163952788-163952789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547893075 | chr3:163952815-163952816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187099447 | chr3:163952843-163952844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191807898 | chr3:163953033-163953034 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539247626 | chr3:163953040-163953041 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183939634 | chr3:163953071-163953072 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540522799 | chr3:163953078-163953079 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190166767 | chr3:163953147-163953148 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143636597 | chr3:163953161-163953162 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567006713 | chr3:163953162-163953163 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144103809 | chr3:163953213-163953214 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371137599 | chr3:163953260-163953261 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562219524 | chr3:163953262-163953263 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148697220 | chr3:163953266-163953267 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368963190 | chr3:163953280-163953281 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539232184 | chr3:163953421-163953422 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558693317 | chr3:163953442-163953443 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Alcoholism | 21790672 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute myeloid leukemia | 19651600 | CNVD |
Autism | 19287141 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Rett syndrome | 21593744 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 20531469 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163948800-163953000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr3:163948800-163953000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:163952400-163953600 | Enhancers | Fetal Kidney | kidney |
4 | chr3:163953000-163953600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr3:163953000-163959200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr3:163953600-163954800 | Weak transcription | Fetal Kidney | kidney |
7 | chr3:163954800-163955600 | Enhancers | Fetal Kidney | kidney |
8 | chr3:163959200-163962000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:163962000-163962600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:163962600-163963200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:163963200-163995200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:163979000-163996200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr3:163982400-163983200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr3:163990800-163993200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr3:163994400-163995200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
16 | chr3:163995200-164000600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr3:163996200-163997000 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
18 | chr3:164000600-164002200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr3:164002200-164003000 | Genic enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr3:164003000-164005600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |